These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26232342)

  • 41. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.
    Zhang J; Fan HY; Zhang Z; Zhang J; Zhang J; Huang JN; Ye Y; Liao M
    Vaccine; 2016 Jan; 34(5):622-629. PubMed ID: 26724200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
    Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
    Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens.
    Mallick AI; Kulkarni RR; St Paul M; Parvizi P; Nagy E; Behboudi S; Sharif S
    Viral Immunol; 2012 Jun; 25(3):226-31. PubMed ID: 22512311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
    Swayne DE; Beck JR; Mickle TR
    Avian Dis; 1997; 41(4):910-22. PubMed ID: 9454926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Kim KH; Bhatnagar N; Subbiah J; Liu R; Pal SS; Raha JR; Grovenstein P; Shin CH; Wang BZ; Kang SM
    Virology; 2024 Jul; 595():110097. PubMed ID: 38685171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.
    Balzli CL; Bertran K; Lee DH; Killmaster L; Pritchard N; Linz P; Mebatsion T; Swayne DE
    Vaccine; 2018 Jan; 36(1):84-90. PubMed ID: 29180030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
    Kammoun H; Roux X; Raze D; Debrie AS; De Filette M; Ysenbaert T; Mielcarek N; Saelens X; Fiers W; Locht C
    PLoS One; 2013; 8(3):e59198. PubMed ID: 23555631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.
    Lee DH; Park JK; Lee YN; Song JM; Kang SM; Lee JB; Park SY; Choi IS; Song CS
    Vaccine; 2011 May; 29(23):4003-7. PubMed ID: 21463681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective efficacy of Fc targeting conserved influenza virus M2e antigen expressed by Lactobacillus plantarum.
    Yang WT; Yang GL; Wang Q; Huang HB; Jiang YL; Shi CW; Wang JZ; Huang KY; Jin YB; Wang CF
    Antiviral Res; 2017 Feb; 138():9-21. PubMed ID: 27908830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
    Stepanova LA; Kovaleva AA; Potapchuk MV; Korotkov AV; Kupriianov VV; Blokhina EA; Kotliarov RIu; Tsybalova LM
    Vopr Virusol; 2013; 58(3):21-5. PubMed ID: 24006628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
    Shokouhi H; Farahmand B; Ghaemi A; Mazaheri V; Fotouhi F
    Virus Res; 2018 Jun; 251():40-46. PubMed ID: 29730305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved design and intranasal delivery of an M2e-based human influenza A vaccine.
    De Filette M; Fiers W; Martens W; Birkett A; Ramne A; Löwenadler B; Lycke N; Jou WM; Saelens X
    Vaccine; 2006 Nov; 24(44-46):6597-601. PubMed ID: 16814430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine.
    Swayne DE; Eggert D; Beck JR
    Vaccine; 2012 Jul; 30(33):4964-70. PubMed ID: 22652397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge.
    Ma JH; Yang FR; Yu H; Zhou YJ; Li GX; Huang M; Wen F; Tong G
    Virol J; 2013 Jul; 10():227. PubMed ID: 23834899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection.
    Garcia A; Johnson H; Srivastava DK; Jayawardene DA; Wehr DR; Webster RG
    Avian Dis; 1998; 42(2):248-56. PubMed ID: 9645315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.
    Lambrecht B; Steensels M; Van Borm S; Meulemans G; van den Berg T
    Avian Dis; 2007 Mar; 51(1 Suppl):221-6. PubMed ID: 17494557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A candidate dual vaccine against influenza and noroviruses.
    Xia M; Tan M; Wei C; Zhong W; Wang L; McNeal M; Jiang X
    Vaccine; 2011 Oct; 29(44):7670-7. PubMed ID: 21839795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus.
    Qiao C; Jiang Y; Tian G; Wang X; Li C; Xin X; Chen H; Yu K
    Antiviral Res; 2009 Mar; 81(3):234-8. PubMed ID: 19110002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.